Close Menu

CHICAGO – Startup bioinformatics vendor Deep Lens is now integrating molecular data into its core platform for clinical trial screening and enrollment, thanks to an exclusive deal to license technology developed at the University of Miami.

Last month, Columbus, Ohio-based Deep Lens licensed an integration engine developed by the Sylvester Comprehensive Cancer Center and UHealth Information Technology, both part of the University of Miami.

Get the full story with
Premium Access

Only $95 for the
first 90 days*

Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try Premium Access now.

You may already have institutional access!

Check if I qualify.

Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.